» Articles » PMID: 39016445

Cancer Mortality by Country of Birth and Cancer Type in Sweden: A 25-year Registry-based Cohort Study

Overview
Journal Cancer Med
Specialty Oncology
Date 2024 Jul 17
PMID 39016445
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies have reported lower overall cancer mortality rates among immigrants compared to native populations. However, limited information exists regarding cancer mortality among immigrants based on specific birth countries and cancer types. We used population-based registries and followed 10 million individuals aged 20 years or older in Sweden between 1992 and 2016. The Cox proportional hazard model was used to explore the disparities in cancer mortality by country of birth and cancer type, stratified by gender. Age-standardized mortality rates were also computed using the world standard population. Hazard ratio (HR) of all-site cancer was slightly lower among immigrants (males: HR = 0.97: 95% confidence interval: 0.95, 0.98; females: HR = 0.93: 0.91, 0.94) than Swedish-born population. However, the immigrants showed higher mortality for infection-related cancers, including liver (HR = 1.10: 1.01, 1.19; HR = 1.10: 1.02, 1.17), stomach (HR = 1.39: 1.31, 1.49; HR = 1.33: 1.26, 1.41) cancers, and tobacco-related cancers, including lung (HR = 1.44: 1.40, 1.49), and laryngeal cancers (HR = 1.47: 1.24, 1.75). The HR of mesothelioma was also significantly higher in immigrants (HR = 1.44: 1.10, 1.90). Mortality from lung cancer was specifically higher in men from Nordic (HR = 1.41: 1.27, 1.55) and non-Nordic Europe (HR = 1.49: 1.43, 1.55) countries and lower in Asian (HR = 0.78: 0.66, 0.93) and South American men (HR = 0.70: 0.57, 0.87). In conclusion, there are large variations in cancer mortality by country of birth, and cancer type and require regular surveillance. Our detailed analyses lead to some novel findings such as excess mortality rate of mesothelioma and laryngeal cancers in Immigrants in Sweden. A targeted cancer prevention program among immigrants in Sweden is needed.

Citing Articles

Global, regional, and national mortality of larynx cancer from 1990 to 2021: results from the global burden of disease study.

Han D, Lee H, Oung Q, Lee C World J Surg Oncol. 2025; 23(1):76.

PMID: 40055712 PMC: 11887237. DOI: 10.1186/s12957-025-03720-6.


Cancer mortality by country of birth and cancer type in Sweden: A 25-year registry-based cohort study.

Tollosa D, Zendehdel K, Procopio A, Cederstrom A, Boffetta P, Pukkala E Cancer Med. 2024; 13(14):e70020.

PMID: 39016445 PMC: 11253184. DOI: 10.1002/cam4.70020.

References
1.
Stirbu I, Kunst A, Vlems F, Visser O, Bos V, Deville W . Cancer mortality rates among first and second generation migrants in the Netherlands: Convergence toward the rates of the native Dutch population. Int J Cancer. 2006; 119(11):2665-72. DOI: 10.1002/ijc.22200. View

2.
Wallace M . Mortality Advantage Reversed: The Causes of Death Driving All-Cause Mortality Differentials Between Immigrants, the Descendants of Immigrants and Ancestral Natives in Sweden, 1997-2016. Eur J Popul. 2022; 38(5):1213-1241. PMC: 9727037. DOI: 10.1007/s10680-022-09637-0. View

3.
Mousavi S, Sundquist K, Hemminki K . Morbidity and mortality in gynecological cancers among first- and second-generation immigrants in Sweden. Int J Cancer. 2011; 131(2):497-504. DOI: 10.1002/ijc.26395. View

4.
Honkaniemi H, Bacchus-Hertzman J, Fritzell J, Rostila M . Mortality by country of birth in the Nordic countries - a systematic review of the literature. BMC Public Health. 2017; 17(1):511. PMC: 5445314. DOI: 10.1186/s12889-017-4447-9. View

5.
Huang J, Chan S, Pang W, Chow S, Lok V, Zhang L . Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study. J Thorac Oncol. 2023; 18(6):792-802. DOI: 10.1016/j.jtho.2023.01.095. View